首页> 外文期刊>Contrast media & molecular imaging >Evaluation of EuIIa??based positive contrast enhancement after intravenous, intraperitoneal, and subcutaneous injections
【24h】

Evaluation of EuIIa??based positive contrast enhancement after intravenous, intraperitoneal, and subcutaneous injections

机译:静脉,腹膜内和皮下注射后基于EuIIaβ的阳性对比增强效果的评估

获取原文
           

摘要

EuIIa??based contrast agents offer physiologically relevant, metala??based redox sensing that is unachievable with GdIIIa??based contrast agents. To evaluate the in vivo contrast enhancement of EuII as a function of injection type, we performed intravenous, intraperitoneal, and subcutaneous injections in mice. Our data reveal a correlation between reported oxygen content and expected rates of diffusion with the persistence of EuIIa??based contrast enhancement. Biodistribution studies revealed europium clearance through the liver and kidneys for intravenous and intraperitoneal injections, but no contrast enhancement was observed in organs associated with clearance. These data represent a step toward understanding the behavior of EuIIa??based complexes in vivo. Copyright ?? 2016 John Wiley & Sons, Ltd.
机译:基于EuIIa +的造影剂提供了生理相关的基于金属a-的氧化还原传感,这是基于GdIIIa 10的造影剂无法实现的。为了评估EuII的体内对比增强与注射类型的关系,我们在小鼠中进行了静脉内,腹膜内和皮下注射。我们的数据揭示了所报告的含氧量与预期的扩散速率之间的相关性,以及基于EuIIa-的对比增强的持久性。生物分布研究表明,对于静脉内和腹膜内注射,euro通过肝脏和肾脏清除,但是在清除相关器官中未观察到对比增强。这些数据代表了迈向了解基于EuIIaβ的复合物在体内的行为的一步。版权?? 2016 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号